Inloggen
Inloggen
Of aanmelden met
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     
Registreer
Of aanmelden met
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     

Toonaangevende leiders

HomepaginaAl het nieuwsHet meest gelezen nieuwsBiografieën van bedrijfsleiders 
Portrait de Duncan Charles Mcnaught Moore
Leeftijd : 61
Vermogen : 26 527 USD
Belangrijkste bedrijven : GH Research PLC - Allarity Therapeutics, Inc. - Forward Pharma A/S
Overzicht 
Duncan Charles Mcnaught Moore is a businessperson who founded Ultraclone Ltd. and who has been at the head of 7 different companies. Currently, Dr. Moore holds the position of Chairman for Lamellar Biomedical Ltd., Chairman of Allarity Therapeutics A, Chairman at Allarity Therapeutics, Inc., Chairman at Allarity Therapeutics Europe ApS (a subsidiary of Allarity Therapeutics, Inc.), Deputy Chairman at Braidlock Ltd. and Partner at East West Capital Partners Pte Ltd.

He is also Chairman for Scottish Lifesciences Association and on the board of 5 other companies.

In his past career Dr. Moore was Chairman of StepJockey Ltd., Chairman of Oncology Venture Sweden AB and Research Analyst at Morgan Stanley & Co. International Plc.

Dr. Moore received an undergraduate degree from the University of Leeds and a doctorate and a graduate degree from the University of Cambridge.


Posities en verantwoordelijkheden van Duncan Charles Mcnaught Moore 
NaamTitel Van
GH Research PLC
(Biotechnologie & Medisch Onderzoek)
Non-Executive Director 2021
Allarity Therapeutics, Inc.
(Biotechnologie & Medisch Onderzoek)
Chairman 2021
Forward Pharma A/S
(Biotechnologie & Medisch Onderzoek)
Independent Director 2016
Lamellar Biomedical Ltd. Chairman 2013
Allarity Therapeutics Europe ApS Chairman 2015
Scottish Lifesciences Association Chairman -
Allarity Therapeutics A/S Chairman 2018
Merchiston Castle School Deputy Chairman-Governors Board -
Braidlock Ltd. Deputy Chairman -
Cycle Pharmaceuticals Ltd. Director 2014
ASP Isotopes, Inc. Director 2021
East West Capital Partners Pte Ltd. Partner 2008


Belangnemingen van Duncan Charles Mcnaught Moore 
NaamAandelen%Totale waarde
Allarity Therapeutics, Inc. (ALLR)
(Biotechnologie & Medisch Onderzoek)
22 6730,23%26 527 USD


Duncan Charles Mcnaught MoorePersoonlijk netwerk 
Meest gelezen nieuws 
29/09Buffett's Berkshire Hathaway koopt 5,99 mln extra aandelen Occidental
MR
26/09De soap van Unilever: Fusies en overnames, banenreducties, Nelson Peltz in de raad van bestuur
MR
05/10Musk zegt dat Twitter-deal 'versneller' is om 'alles-app' te creëren
MR
26/09Twitter interviewt Elon Musk, bekend om strijdlustige getuigenissen
MR
28/09Elon Musk wil toestemmingsovereenkomst SEC versmallen, einde aan voorafgaande goedkeuring van tweets
MR
29/09De lange, bochtige weg naar de beursgang van Volkswagen's Porsche
MR
26/09Getuigenissen van Musk, Twitter's Agrawal zijn uitgesteld - bronnen
MR
Meer nieuws


© 2022 People and Ownership :   
Duncan Charles Mcnaught Moore Verbindingen